ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025
2026-02-04 13:32:33 ET
More on related tickers
- Trane Technologies: Upgrade To Buy On Cheaper Valuation And Better Fundamentals
- Roche Holding AG (RHHBY) Q4 2025 Earnings Call Transcript
- Linde Q4 2025 Earnings Preview
- Genentech in up to $1.7B RNAi licensing deal with SanegeneBio
Read the full article on Seeking Alpha
For further details see:
ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025NASDAQ: RYAOF
RYAOF Trading
-12.86% G/L:
$30.01 Last:
100 Volume:
$30.01 Open:



